4.1.4.2.5. placebo nocebo. placebo clear effect improvement oab signs symptoms, overall placebo responses various outcomes studied statistically significant and, outcomes, possibly clinically significant. recent sr including 57 studies 12,901 patients showed standardised mean difference -0.45 daily micturition episodes, -0.33 daily nocturia episodes, -0.46 uui episodes, -0.50 daily urgency episodes, -0.51 daily incontinence episodes, 0.25 volume voided per micturition . group published sr meta-analysis data retrieved 57 rcts nocebo effect pharmacotherapy patients oab (up 80% females). reported dry mouth common reported adverse event mean rate 4.9%, followed constipation 2.6%. authors concluded hcps appreciate possible positive negative patient expectation regarding pharmacotherapy oab order optimise individual outcomes . placebo response seems non-negligible oab, supporting requirement placebo control rcts.